Established in 1996, Jusha is a global medical high-tech enterprise headquartered in Gulou District, Nanjing. It has established a Science and Technology Industrial Park in Nanjing Jiangbei National High-tech Zone. The company owns three wholly-owned companies and a holding company. It is mainly engaged in the R&D, production and sales of the intelligent video center, intelligent operating room, intelligent medical high-pressure injector and consumables, intelligent operating robot, and infection control solutions for hospitals. Also, Jusha has its independent live streaming platform for medical operations.
Jusha has a R&D team that accounts for 30% of the company's total employees. Each year, Jusha makes an investment that is equal to more than 16% of its annual turnover. The company has three R&D centers in Nanjing, Shanghai and Shenzhen, as well as an overseas R&D department in the UK. Jusha has established the Enterprise Technology Center, Industrial Design Center, Medical Image Precise Display Engineering Technology R&D Center, Medical Image Processing Engineering Center and other research platforms. Currently, Jusha has applied for more than 800 international and domestic proprietary technologies and won the honorary title of national intellectual property model enterprise. Among these technologies, the international patents of invention for the precise recognition and processing of medical images, self-adaptive processing for intelligent positioning and enhancement of lesions, and biological indication for medical infection control based on genetic engineering have filled in the gap of the professional field.
Jusha has eight offices and after-sales service centers around the world. In 2019, the medical display products of Jusha had a market share of 63.1% in the Chinese market. The products were sold to more than 80 countries and regions, serving two billion people worldwide. At present, Jusha has become a leader in the field of digital visualization for medical images in the world.
In recent years, Jusha has increased R&D investments in medical image cloud platforms, radioactive imaging equipments, biological monitoring of infection control, as well as electronic monitoring and interpretation, etc. It has made its own unique and valuable contribution to human health while creating value for global customers.